2020
DOI: 10.1186/s40658-020-00316-9
|View full text |Cite
|
Sign up to set email alerts
|

RECOMIA—a cloud-based platform for artificial intelligence research in nuclear medicine and radiology

Abstract: Background: Artificial intelligence (AI) is about to transform medical imaging. The Research Consortium for Medical Image Analysis (RECOMIA), a not-for-profit organisation, has developed an online platform to facilitate collaboration between medical researchers and AI researchers. The aim is to minimise the time and effort researchers need to spend on technical aspects, such as transfer, display, and annotation of images, as well as legal aspects, such as de-identification. The purpose of this article is to pr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
65
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2

Relationship

3
3

Authors

Journals

citations
Cited by 55 publications
(67 citation statements)
references
References 12 publications
1
65
0
Order By: Relevance
“…The study was approved by the local research ethics at Universities of Gothenburg, Sweden (295-08;2016/103) and Lund, Sweden (LU552/2007). The AI-based method was trained using a retrospective set of CT scans from 50 patients with lymphoma, who had undergone 18 F-fluorodeoxyglucose PET/CT examinations between January 2011 and August 2012. The patients of the training group (18 female and 32 male patients) had a mean age of 61 years (range 41-81) and a mean body weight of 78 kg (range 53-114).…”
Section: Patientsmentioning
confidence: 99%
See 4 more Smart Citations
“…The study was approved by the local research ethics at Universities of Gothenburg, Sweden (295-08;2016/103) and Lund, Sweden (LU552/2007). The AI-based method was trained using a retrospective set of CT scans from 50 patients with lymphoma, who had undergone 18 F-fluorodeoxyglucose PET/CT examinations between January 2011 and August 2012. The patients of the training group (18 female and 32 male patients) had a mean age of 61 years (range 41-81) and a mean body weight of 78 kg (range 53-114).…”
Section: Patientsmentioning
confidence: 99%
“…A completely separate test set consisted of patients who had been part of a previous study investigating the value of PET/CT for staging of prostate cancer [17]. Each patient with biopsy-proven prostate cancer had undergone two PET/CT studies prior to treatment, one 18 F-fluorocholine PET/CT and one 18 F-fluoride PET/CT. From this retrospective group, we excluded five patients with more than two-week interval between the PET/CT studies, assuming that the volumes of SAT and muscle are relatively unchanged during a 2-week period.…”
Section: Patientsmentioning
confidence: 99%
See 3 more Smart Citations